Wei, Xian <br/><br/>
Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.  [electronic resource] 

 -  Experimental eye research  03 2018 
 - 2-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0007 
<br/><br/><label>Standard No.: </label>10.1016/j.exer.2017.12.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Analysis of Variance<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Choroidal Neovascularization--drug therapy<br/>Disease Models, Animal<br/>Humans<br/>Mice<br/>Phenylurea Compounds--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinolines--pharmacology<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Wet Macular Degeneration--drug therapy